+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Combined Immune Deficiency"

Pediatric Allergy,An Issue of Immunology and Allergy Clinics. The Clinics: Internal Medicine Volume 39-4 - Product Thumbnail Image

Pediatric Allergy,An Issue of Immunology and Allergy Clinics. The Clinics: Internal Medicine Volume 39-4

  • Book
  • September 2019
Pediatric Immunology and Allergy, An Issue of Pediatric Clinics of North America. The Clinics: Internal Medicine Volume 67-1 - Product Thumbnail Image

Pediatric Immunology and Allergy, An Issue of Pediatric Clinics of North America. The Clinics: Internal Medicine Volume 67-1

  • Book
  • August 2019
  • North America
  • 2 Results (Page 1 of 1)
Loading Indicator

The Combined Immune Deficiency (CID) market is a subset of the Allergy and Immunology field. CID is a group of rare, inherited disorders that affect the body's ability to fight off infections. People with CID have a weakened immune system, making them more susceptible to infections and other health problems. Treatment for CID typically involves medications, such as antibiotics, antivirals, and immunoglobulins, as well as lifestyle changes, such as avoiding contact with people who have infections. CID is a growing market, with an increasing number of patients seeking treatment. As a result, there is a need for more research and development of treatments and therapies. Companies in the CID market are focused on developing new treatments and therapies, as well as providing support and education to patients and their families. Some companies in the CID market include AbbVie, Amgen, AstraZeneca, Biogen, Gilead Sciences, and Novartis. Show Less Read more